Financing - February 19, 2018
Catalyze opens new office in Copenhagen
Catalyze has opened the doors to their new office at the Copenhagen Bio Science Park (COBIS). From this office, Catalyze, a consulting firm specialized in non-dilutive funding, will be able to better serve its existing and new clients in Medicon Valley and the rest of the Nordics according to the company. The office in Copenhagen is […]
Financing - January 23, 2018
Nexstim receives R&D loan from Business Finland
The medtech company announces that Business Finland has granted them an R&D loan amounting to approximately EUR 1 million for the development of a next-generation user interface (GUI) for the Navigated Brain Therapy (NBT) System indicated for the treatment of Major Depressive Disorder (MDD) and chronic neuropathic pain. To enable extensive therapeutic use of the […]
Business article - January 19, 2018
A very strong year for life science funding in Scandinavia
A new report from Industrifonden shows that life science companies in Scandinavia raised $2.2bn in 2017, doubling from 2016 and equivalent to the total funding amount for 2014-2016 ($2.4bn), with strong growth across IPOs, refunds and venture funding. The new report also states that biotech/pharma raised a total of $500m through IPOs, equivalent to 12% of the […]
Biotech Business - January 8, 2018
Cytovation completes financing round of 30 million NOK
Cytovation has raised NOK 10m in a private funding round, completing the second stage of fundraising, having raised NOK 20m in June 2017. Both financings were led by a group of private investors in Norway and the company will now use these funds to advance lead product CyPep-H1 through the final stages of pre-clinical development and […]
Financing - December 15, 2017
SciBase secures SEK 75 million
SciBase Holding announces that the secured new share issue with preferential rights for existing shareholders has been completed and will provide the company with approximately SEK 75 million before deduction of transaction costs. A total of approximately SEK 39.2 million, corresponding to 46.1 percent of the full offering was subscribed for. Approximately SEK 36.6 million, […]
Financing - November 27, 2017
Vironova awarded funding for AI and machine learning
Vironova has been awarded funding for a two-year research project entitled “Interactive visualization tools for verification and improvement of deep neural network predictions.” The project will stretch over two years (Jan 2018- Dec 2019) and represents a collaboration of strategical importance to Vironova in the areas of Artificial Intelligence (AI) and Machine Learning, applied to […]
